Wake Forest University Baptist Health

Winston-Salem, North Carolina 27157

3 studies enrolling now · 7 studies all time

What they study most

AML, Androgenic Alopecia, EPP, Erythropoietic Protoporphyria (EPP), Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma, Pancreatic Adenocarcinoma, Psoriasis, X-Linked Protoporphyria (XLP), XLP

Studies at this site

• A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer — Recruiting now
• Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP) — Recruiting now
• Evaluating the Efficacy of Platelet-rich Plasma Therapy in the Treatment of Androgenic Alopecia — Starting soon
• INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP — Completed
• Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria — Completed
• A Priming Intervention to Increase Patient Willingness to Use Injectables for the Management of Psoriasis — Completed
• (QuANTUM-R): An Open-label Study of Quizartinib Monotherapy vs. Salvage Chemotherapy in Acute Myeloid Leukemia (AML) Subjects Who Are FLT3-ITD Positive — Completed